TODAY’S HEADLINES
Cantimer takes in $2M for dehydration diagnostics (VentureWire)
Recodagen launches, takes aim at cancer (release)
Juniper Diagnostics spins out of ChemSensing (VentureWire)
Cantimer takes in $2M for dehydration diagnostics –The mystery of Menlo Park, Calif.-based Cantimer has resolved a bit. We wrote about this stealthy company back in December and reached the conclusion that the company [...]
TODAY’S HEADLINES:
Aperio Tech raises $20M for digital pathology (release)
TissueLink changes name, files for $86M IPO (Edgar)
Specialty pharma Cydex files to raise $50M in IPO (Edgar)
Hydra Biosciences takes in $34M for pain drugs (VentureWire)
AVI BioPharma acquires Ercole Biotech for $9M (release)
Juvaris Bio names Grant Pickering as CEO (release)
Aperio Tech raises $20M for digital pathology – Aperio [...]
Most Health 2.0 startups operate on some variation of the Field of Dreams model, hoping that if they build an innovative new service, patients and doctors will come and use it. A few, however, are making more like Willie Sutton — the fellow who, when asked why he robbed banks, replied, “That’s where the money [...]
TODAY’S HEADLINES:
EyeGate Pharma takes in $15M for eye-drug delivery (release)
Pronostics raises £3M for autoimmune diagnostics (VentureWire)
TPG Biotech funds development of Japanese growth hormone, EPO (release)
Immucor acquires gene- and protein-chip maker BioArray for $117M (release)
Phase Bioscience gets $1M loan for protein purification (release)
The Web-based health-management tools collectively known as Health 2.0 generally suffer from a major shortcoming, in that they typically put the onus on individuals to learn about them and put them to use. But a few startups are taking an interesting new tack by getting health insurers to offer their Health 2.0 services to their [...]
TODAY’S HEADLINES:
Affinergy gets $3M in grants for biological “linkers” (release)
Specialty pharma EUSA raises $50M, spends $23M for public biotech Cytogen (release)
Calderome takes in $12M for cancer diagnostics (peHUB)
Pulse Health raises $2M for handheld free-radical device (release)
LifeMasters takes in $15M for wellness, disease-management programs (release)
Dubai Techno Park launched $300MVC fund for life sciences, other sectors [...]
TODAY’S HEADLINES:
BrainCells raises $30M for neuroregeneration drugs (release)
EKR Therapeutics takes in $50M plus $95M in debt for pain, heart drugs (release)
Wright Medical acquires Berkeley’s Inbone Tech for $24M (release)
Argolyn Bioscience names Nixon Ellis as CEO (release)
BrainCells raises $30M for neuroregeneration drugs – San Diego’s BrainCells, a startup focused on drugs intended to stimulate the growth [...]
TODAY’S HEADLINES:
Allegro pulls in $4M for lung-cancer molecular diagnostics (release)
Ocular bandage developer I-Therapeutix raises $6M (Mass High Tech)
NanoBio gets last of $30M for skin-infection drugs (release)
Cayenne Medical raises $15M for sports medicine (release)
Aridis Pharma seeks $10M for oral-form drugs and vaccines (VentureWire)
Neurosurgical device maker Nfocus Neuro acquires StarFire Medical (release)
Allegro pulls in [...]
The Health 2.0 conference earlier this week was crammed with startups all touting their plans for transforming the broken U.S. healthcare system via innovative technology that empowers patients. Many of these companies are all essentially offering variations on the same themes, but six stood out for their efforts to reinvent the doctor-patient relationship in new [...]
(UPDATED: Added screenshots and a link to video of the Myca patient-record interface.)
The just-concluded Health 2.0 Conference in San Diego showcased some 30-odd startups and Web sites — with dozens more in the audience — all intent on using the Internet to improve patient care, streamline healthcare practices and bolster the ability of individuals to [...]
TODAY’S HEADLINES:
France’s TxCell raises €11M for cell therapy (release)
Healthcare IT firm TriHealix takes in $7M (release)
Healthcare-software provider Anodyne Health acquires Piedmont Healthcare (release)
CEO, CFO resign at inhaled-drug biotech Topigen (release)
France’s TxCell raises €11M for cell therapy – TxCell, a French cell-therapy biotech, raised €10.5 million ($16 million) in a second funding [...]
(UPDATED: See below.)
Another one bites the dust.
The saga of Precision Therapeutics, a Pittsburgh biotech developing what struck me last August as a particularly crude type of cancer-chemotherapy diagnostic, continues apace. In a tersely worded press release, the special-purpose acquisition company, or SPAC, Oracle Healthcare Acquisition said it has terminated its planned merger with Precision. The [...]
TODAY’S HEADLINES:
Precision Thera merger with “blank check” Oracle Healthcare collapses (release)
Sleep Solutions takes in $21M for sleep-apnea diagnostics (release)
Trevena takes in $24M for drugs targeting G-proteins (release)
“Specialty biotech” PanGenetics gets €23M for antibody drugs (release)
Cancer-drug maker Unibioscreen pulls in €5M (release)
Danish contract manufacturer CMC Biologics raises new funding (PDF [...]
TODAY’S HEADLINES:
Moberg Derma gets $4.5M for skin-disease treatments (PDF release)
Chesson Labs takes in $3.3M for liquid skin bandage (bizjournals.com)
TVM Capital takes stake in German pharma Riemser Arzneimittel (release)
Cardinal Health acquires skin-disinfectant maker Enturia for $490M (release)
For empowered “medical consumers” to really transform the healthcare system, as Health 2.0 proponents would have, clear pricing and quality data for medical care is essential. Unfortunately, such information is currently in short supply.
The startup change:healthcare aims to fill that void with a revamped Web site, just launched this afternoon. And it’s a nifty idea, [...]
Can social networking help restrain, or even lower, healthcare costs? The Nashville, Tenn., startup change:healthcare is primed to find out.
Healthcare plans are inexorably forcing more cost-sharing on patients — a strategy some call YOYO, for “you’re on your own” — which means that the actual cost of medical care is looming larger for many Americans. [...]
© 2004-2008(c) Matt Marshall. All rights reserved.
